Introduction To Order Related Products Introduction Base modified NTPs have been widely used for synthesis of modified mRNA to improve stability and reduce immunogenicity. ABP Biosciences offers a list of key base modified NTPs for mRNA synthesis. Cat. No. Product Name Unit Size LP009-1 N1-Methylpseudo-UTP 10 µL LP009-2 N1-Methylpseudo-UTP 50 µL LP009-3 N1-Methylpseudo-UTP 100 µL […]
Continue Reading
Home » Articles posted byYLQ (Page 9)
Author Archives: YLQ
5-Methyl-CTP
Introduction To order Documents Related Products Introduction 5-Methyl-CTP (5-Methylcytidine-5'-Triphosphate) is a modified nucleoside triphosphate employed to impart desirable characteristics such as increased nuclease stability, increased translation or reduced interaction of innate immune receptors with in vitro transcribed RNA. 5-Methyl-CTP, as well as Pseudo-UTP and N1-Methylpseudo-UTP, have been shown to reduce innate immune stimulation in culture […]
Continue Reading
Pseudo-UTP
Introduction To order Documents Related Products Introduction Pseudo-UTP (Pseudouridine-5'-Triphosphate) is one of the most commonly used modified nucleoside-5’-O-triphosphates. Pseudo-UTP is a building block for the polymerase-mediated synthesis of RNA molecules. RNA molecules, especially messenger RNAs (mRNAs), have widespread applications in therapeutic and diagnostic areas, and have demonstrated their superiority over plasmid DNA techniques in both […]
Continue Reading
N1-Methylpseudo-UTP
Introduction To order Documents Related Products Introduction N1-Methylpseudo-UTP (N1-Methyl-Pseudouridine-5'-Triphosphate) is a modified NTP for incorporation into messenger RNAs (mRNA) using T7 RNA Polymerase. Incorporation of N1-methylpseudouridine can reduce the immunogenicity of the resulting mRNA. It was reported that N1-methylpseudouridine (m1Ψ) modification alone or in combination with 5-methylcytidine (m5C) exhibited superiority over the current state-of-the-art pseudouridine […]
Continue Reading
Lipid Nanoparticles (LNPs)
Introduction To Order Related Products Introduction Lipid Nanoparticles (LNPs) play important role for delivery of mRNA-based vaccines. ABP Biosciences offers a list of key lipids for formulation of Lipid Nanoparticles (LNPs). Lipid Role SM-102 Ionizable amino lipid ALC-0315 Ionizable amino lipid ALC-0159 Coating Lipid DMG-PEG2000 Coating Lipid DSPC Structural/Helper […]
Continue Reading
LNP-0315
Introduction To order Documents Related Products Introduction LNP-0315 is a lipid nanoparticle (LNP) formulated with ALC-0315, DSPC, Cholesterol, and ALC-0159. LNP-0315 is formulated at optimal molar ratio for efficient delivery of mRNA-based vaccines. LNP-0315 is supplied at 10 mg/mL stock solution in ethanol. For research use only. To order Buy Cat.No. Product name Size Price LP008-1 LNP-0315 1 mL […]
Continue Reading LNP-102
Introduction To order Documents Related Products Introduction LNP-102 is a lipid nanoparticle (LNP) formulated with SM-102, DSPC, Cholesterol, and DMG-PEG2000. LNP-102 is formulated at optimal molar ratio for efficient delivery of mRNA-based vaccines. LNP-102 is supplied at 10 mg/mL stock solution in ethanol. For research use only. To order Buy Cat.No. Product name Size Price LP007-1 LNP-102 1 […]
Continue Reading
1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE)
Introduction To order Documents Related Products Introduction 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) is a neutral phospholipid containing 18:1 fatty acids at the sn–1 and sn–2 positions. The compound displays sensitivity towards pH change. At acidic it is an inverted hexagonal micelle and transforms to spherical micelle at alkaline pH. DOPE can be used as an emulsifier to facilitate DNA-liposome complex […]
Continue Reading
1,2-Distearoyl-sn-glycero-3-phosphorylcholine (DSPC)
Introduction To order Documents Related Products Introduction 1,2-Distearoyl-sn-glycero-3-phosphorylcholine (DSPC) is a phospholipid containing the saturated long-chain (18:0) stearic acid inserted at the sn–1 and sn–2 positions. It has been used in combination with other lipids in the formation of lipid nanoparticles (LNPs). Formulations containing DSPC have been used in the development of lipid nanoparticles for the delivery of […]
Continue Reading
DMG-PEG2000
Introduction To order Documents Related Products Introduction DMG-PEG(2000) is a lipid excipient that has been used in combination with other lipids in the formation of lipid nanoparticles (LNPs). Formulations containing DMG-PEG(2000) have been used in the development of lipid nanoparticles for the delivery of mRNA-based vaccines. For research use only. Technical Information Formal […]
Continue ReadingCopyright@ 2025 ABP Biosciences, LLC. All Rights Reserved.
